Birch Triterpenes
Small Molecule
Overview
Birch Triterpenes is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4650246).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Birch Triterpenes expires 4 Jan 2039 and exclusivity 18 Dec 2030. Generic API sourcing typically opens up once these lapse.
Verified Supplier Partner
Do you supply Birch Triterpenes? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.